|
|
|
|
LEADER |
00906nam a2200265 ib4500 |
001 |
NSK01000836894 |
003 |
HR-ZaNSK |
005 |
20160819130003.0 |
007 |
ta |
008 |
130318s2011 sw a i000 0 eng |
020 |
|
|
|a 9789291933150
|
035 |
|
|
|a (HR-ZaNSK)000836894
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
044 |
|
|
|a sw
|a po
|
080 |
1 |
|
|a 616.9-084
|2 MRF 2011.
|
080 |
1 |
|
|a 613.83
|2 MRF 2011.
|
245 |
0 |
0 |
|a Drug treatment for preventing hepatitis C, HIV and injecting risk behaviour.
|
300 |
|
|
|a IV, 37 str. :
|b ilustr.
|
504 |
|
|
|a Bibliografija: str. 22-28.
|
650 |
|
7 |
|a Narkomani
|x Bolesti
|x Prevencija
|2 nskps
|
650 |
|
7 |
|a Metadonska terapija
|2 nskps
|
650 |
|
7 |
|a Hepatitis C
|x Prevencija
|2 nskps
|
650 |
|
7 |
|a HIV infekcije
|x Prevencija
|2 nskps
|
774 |
0 |
|
|t Evidence for the effectiveness of interventions to prevent infections among people who inject drugs
|g pt. 2
|
998 |
|
|
|m nmrk1401
|c ktuo160819
|